Rankings
▼
Calendar
NUVL (Nuvalent, Inc.) Stock Financials & Earnings | Market Cap Arena
NUVL
Nuvalent, Inc.
Mkt Cap
$8B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$425M
EPS (TTM)
-$5.85
Free Cash Flow (TTM)
-$275M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$30M
Q2 23
$0
$0
-$34M
Q3 23
$0
$0
-$39M
Q4 23
$0
$0
-$46M
Q1 24
$0
$0
-$53M
Q2 24
$0
$0
-$65M
Q3 24
$0
$0
-$76M
Q4 24
$0
$0
-$86M
Q1 25
$0
$0
-$95M
Q2 25
$0
$0
-$105M
Q3 25
$0
$0
-$113M
Q4 25
$0
$0
-$102M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$24M
-$24M
Q2 23
-$22M
-$22M
Q3 23
-$23M
-$23M
Q4 23
-$30M
-$30M
Q1 24
-$36M
-$36M
Q2 24
-$41M
-$41M
Q3 24
-$46M
-$46M
Q4 24
-$62M
-$62M
Q1 25
-$55M
-$55M
Q2 25
-$77M
-$77M
Q3 25
-$70M
-$70M
Q4 25
-$73M
-$73M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+70.8%
Q2 23
—
+81.8%
Q3 23
—
+90.2%
Q4 23
—
+58.5%
Q1 24
—
+74.1%
Q2 24
—
+91.3%
Q3 24
—
+96.8%
Q4 24
—
+85.8%
Q1 25
—
+80.3%
Q2 25
—
+60.5%
Q3 25
—
+47.6%
Q4 25
—
+18.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$5M
—
Q2 23
$6M
—
Q3 23
$7M
—
Q4 23
$7M
—
Q1 24
$14M
—
Q2 24
$15M
—
Q3 24
$15M
—
Q4 24
$16M
—
Q1 25
$20M
—
Q2 25
$22M
—
Q3 25
$0
—
Q4 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$22M
$8M
Q2 23
$26M
$8M
Q3 23
$30M
$9M
Q4 23
$36M
$11M
Q1 24
$39M
$14M
Q2 24
$49M
$16M
Q3 24
$61M
$16M
Q4 24
$69M
$17M
Q1 25
$74M
$20M
Q2 25
$81M
$24M
Q3 25
$84M
$29M
Q4 25
$68M
$34M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$90M
$360M
$450M
Q2 23
$71M
$360M
$431M
Q3 23
$88M
$325M
$413M
Q4 23
$335M
$385M
$720M
Q1 24
$99M
$593M
$692M
Q2 24
$78M
$580M
$658M
Q3 24
$369M
$799M
$1.2B
Q4 24
$146M
$973M
$1.1B
Q1 25
$121M
$952M
$1.1B
Q2 25
$127M
$878M
$1.0B
Q3 25
$116M
$827M
$943M
Q4 25
$262M
$1.1B
$1.4B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
57M
+5.8%
Q2 23
57M
+0.3%
Q3 23
57M
+0.4%
Q4 23
62M
+8.9%
Q1 24
64M
+3.2%
Q2 24
65M
+0.7%
Q3 24
66M
+1.7%
Q4 24
71M
+8.3%
Q1 25
72M
+0.6%
Q2 25
72M
+0.3%
Q3 25
72M
+0.4%
Q4 25
75M
+4.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$0
40
FY 22
$0
62
FY 23
$0
92
FY 24
$0
142
FY 25
$0
142
marketcaparena.com